HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Friedline, R. H. Articles by Tisch, R. Search for Related Content PubMed PubMed Citation Articles by Friedline, R. H. Articles by Tisch, R.

L-Selectin Is Not Required for T Cell-Mediated Autoimmune Diabetes¹

Randall H. Friedline^*, Carmen P. Wong^*, Douglas A. Steeber, Thomas F. Tedder and Roland Tisch^2,*

^* Department of Microbiology and Immunology, School of Medicine, University of North Carolina, Chapel Hill, NC 27599; and Department of Immunology, Duke University Medical Center, Durham, NC 27710

Administration of anti-L-selectin (CD62L) mAb to neonatal nonobese diabetic (NOD) mice mediates long term protection against the development of insulitis and overt diabetes. These results suggested that CD62L has a key role in the general function of cell-specific T cells. To further examine the role of CD62L in the development of type 1 diabetes, NOD mice lacking CD62L were established. The onset and frequency of overt diabetes were equivalent among CD62L^+/+, CD62L^+/-, and CD62L^-/- NOD littermates. Furthermore, patterns of T cell activation, migration, and cell-specific reactivity were similar in NOD mice of all three genotypes. Adoptive transfer experiments with CD62L^-/- CD4⁺ T cells prepared from BDC2.5 TCR transgenic mice revealed no apparent defects in migration to pancreatic lymph nodes, proliferation in response to cell Ag, or induction of diabetes in NOD.scid recipients. In conclusion, CD62L expression is not essential for the development of type 1 diabetes in NOD mice.

This article has been cited by other articles:

				A. Klinger, A. Gebert, K. Bieber, K. Kalies, A. Ager, E. B. Bell, and J. Westermann Cyclical expression of L-selectin (CD62L) by recirculating T cells Int. Immunol., April 1, 2009; 21(4): 443 - 455. [Abstract] [Full Text] [PDF]

				S. Karumuthil-Melethil, N. Perez, R. Li, and C. Vasu Induction of Innate Immune Response through TLR2 and Dectin 1 Prevents Type 1 Diabetes J. Immunol., December 15, 2008; 181(12): 8323 - 8334. [Abstract] [Full Text] [PDF]

				S. S. Perry, H. Wang, L. J. Pierce, A. M. Yang, S. Tsai, and G. J. Spangrude L-selectin defines a bone marrow analog to the thymic early T-lineage progenitor Blood, April 15, 2004; 103(8): 2990 - 2996. [Abstract] [Full Text] [PDF]

				C. Mora, I. S. Grewal, F. S. Wong, and R. A. Flavell Role of L-selectin in the development of autoimmune diabetes in non-obese diabetic mice Int. Immunol., February 1, 2004; 16(2): 257 - 264. [Abstract] [Full Text] [PDF]

				M.-A. Alyanakian, S. You, D. Damotte, C. Gouarin, A. Esling, C. Garcia, S. Havouis, L. Chatenoud, and J.-F. Bach Diversity of regulatory CD4+T cells controlling distinct organ-specific autoimmune diseases PNAS, December 23, 2003; 100(26): 15806 - 15811. [Abstract] [Full Text] [PDF]